Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Kromek wins US$1.15mln of repeat orders

October was a good month for orders for Kromek, and November has started off well
X-ray
The scanners can detect the early onset of osteoporosis

Kromek Group PLC (LON:KMK) is celebrating repeat orders worth around US$1.15mln for its detector modules from three of its original equipment manufacturer (OEM) customers.

The radiation detection technology company said the orders are from global producers and exporters of bone mineral diagnostic [BMD] systems that incorporate Kromek’s cadmium zinc telluride-based detector modules.

The contracts are expected to be delivered over the next 24 months, with the bulk of the orders expected to be shipped within the next 12 months.

Kromek's detector modules will be incorporated into the OEMs' systems to produce some of the most accurate imaging to diagnose the strength and health of bones, Kromek said.

The CZT-based diagnostic systems will allow clinicians to accurately detect and monitor progression of osteoporosis in patients resulting in more effective treatment.

"It is very pleasing to secure double the orders we received from these long-standing customers last year,” said Dr Arnab Basu, the chief executive officer of Kromek.

“It strengthens our relationship with them and further validates our belief that more and more legacy detection systems are being replaced with BMD diagnostic systems with our CZT detectors. The agreements represent the continued healthy conversion of our pipeline into orders as we continue to win new contracts in the medical sector," he added.

 

View full KMK profile View Profile

Kromek Group PLC Timeline

Related Articles

Westminster Group
April 05 2018
Westminster's pipeline of opportunities is strong in the Middle East
Adult gamer
April 10 2018
Most video games are developed in English, but sales are global and that has created a business in translating games into local languages and cultures.
Picture of XTEK's products
May 04 2018
Patersons' price target of $1.15 implies upside of 130% relative to XTEK's current share price.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use